Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Employee Stock Options

Jeena Sikho Lifecare received BSE in-principle approval to list up to 6,50,000 ESOS 2024 shares. Both NSE and BSE approvals are now in place.

Jeena Sikho Lifecare Product Launch

Jeena Sikho Lifecare has launched two new Ayurvedic products, Acharya Ji's Amrit Tattava Vati and Acharya Ji's Oja Amrit Vati, in the domestic market.

Jeena Sikho Lifecare Capacity Expansion

Jeena Sikho Lifecare postponed its new Lucknow hospital's commercial operations to December 2026 from August. The delay stems from expanded work scope and adverse site weather.

Jeena Sikho Lifecare Business Update

Jeena Sikho Lifecare Limited received NABH accreditation for its Pune hospital, affirming its adherence to quality healthcare standards and operational excellence.

Jeena Sikho Lifecare Product Launch

Jeena Sikho Lifecare launched two new Ayurvedic products, Jeevanodya Vati and Ojavardhan Vati. This expands the company's portfolio of healthcare and wellness offerings.

Jeena Sikho Lifecare Other Announcement

Jeena Sikho Lifecare Limited informed shareholders about the web-link to access its 2025-26 Annual Report and 9th AGM Notice.

Jeena Sikho Lifecare Annual General Meeting

Jeena Sikho Lifecare Limited will hold its 9th Annual General Meeting on September 28, 2026. The notice covers director appointments, reappointments, and a final dividend declaration.

Jeena Sikho Lifecare Earnings Call Transcript: Key Takeaways

Jeena Sikho is aggressively pivoting from low-margin government business to a high-margin cash-and-carry wellness ecosystem. Management is prioritizing operating leverage and 'prevention-first' health models to drive 30% annual growth.

Call

Guides 30% growth

Jeena Sikho Lifecare Investor Presentation: Key Takeaways

JSLL reported Q1FY27 revenue of Rs 224.4 Cr (+29% YoY) with an EBITDA margin of 41%. The company is expanding its integrated Ayurveda model across 2,400 operational beds.

Jeena Sikho Lifecare Q1 FY27 Results: Net Profit ₹65.9 Cr, Up 28.5% YoY

Jeena Sikho Lifecare Ltd reported revenue from operations of ₹224.4 Cr (+28.7% YoY) and net profit of ₹65.9 Cr (+28.5% YoY) for Q1 FY27.

Key figure

Net profit ₹65.9 Cr · +28.5% YoY

Jeena Sikho Lifecare Earnings Call: Key Takeaways

Jeena Sikho delivered strong FY26 results with 71% revenue growth and 177% PAT growth, driven by hospital utilization and high-margin product sales. Management targets 4-5x PAT growth over 3-5 years.

Jeena Sikho Lifecare Earnings Call: Key Takeaways

Jeena Sikho reported stellar FY26 growth, pivoting from government to high-margin private patients. Management used flamboyant, messianic rhetoric to mask ₹21cr in one-time expenses related to auditor-mandated accounting changes and staff bonuses.

Jeena Sikho Lifecare Earnings Call: Key Takeaways

Jeena Sikho reported stellar FY26 performance with Revenue at ₹80,135 Lakhs and PAT at ₹22,218 Lakhs. The company expanded to 2,300 operational beds across 119 centers.

Jeena Sikho Lifecare Earnings Call: Key Takeaways

Jeena Sikho reported strong Q4FY26 results with a 55% YoY revenue surge, driven by expanding Ayurveda healthcare services and product reach.

Jeena Sikho Lifecare Q4 FY26 Results: Net Profit ₹45.1 Cr, Up 78.3% YoY

Jeena Sikho Lifecare Ltd reported revenue from operations of ₹215.6 Cr (+54.8% YoY) and net profit of ₹45.1 Cr (+78.3% YoY) for Q4 FY26.

Key figure

Net profit ₹45.1 Cr · +78.3% YoY